Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

BACKGROUND: Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postmenopausal breast cancer survivors. METHODS: Using a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast
Glavni autori: Sund, Maria, Garcia-Argibay, Miguel, Garmo, Hans, Ahlgren, Johan, Wennstig, Anna-Karin, Fredriksson, Irma, Lindman, Henrik, Valachis, Antonis
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8281646/
https://ncbi.nlm.nih.gov/pubmed/34265496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.07.004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items